Inactive Instrument
Sector Cell Therapeutics Inc Nasdaq
Stocks
US1509346029
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 27/06/23 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
| 27/06/23 | DRI Healthcare Trust Announces USD 54.8 Million Debt Repayment from CTI Biopharma Corp | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.78% | -0.71% | -4.42% | +18.64% | +4.61% | +2.18% | +13.68% | -22.10% | +198.46% | 49.24B | ||
| +0.85% | -0.70% | +10.13% | +36.29% | +155.76% | +465.55% | +579.03% | +695.43% | - | 43.3B | ||
| -2.40% | -0.23% | +13.35% | +14.07% | +14.37% | +12.20% | +70.22% | +23.85% | +1,101.11% | 40.48B | ||
| -2.01% | -0.85% | +13.87% | +38.66% | +4.99% | +24.95% | +7.51% | -7.30% | +209.32% | 39.75B | ||
| -0.50% | +3.08% | +14.79% | +10.79% | +16.60% | +19.91% | +47.26% | -11.26% | +153.13% | 32.67B | ||
| +0.38% | -3.23% | -6.93% | +0.68% | - | - | - | - | - | 16.23B | ||
| -0.59% | -2.06% | +7.89% | +38.01% | +3.00% | +26.13% | +117.79% | +213.13% | +1,879.81% | 16.24B | ||
| +0.49% | +0.80% | +1.35% | +19.76% | +12.88% | +5.45% | +22.29% | -38.08% | +85.05% | 14.04B | ||
| -0.43% | +4.70% | +21.12% | +76.00% | +40.39% | +79.75% | +29.11% | -32.69% | +236.23% | 13.43B | ||
| -2.59% | -0.83% | -2.87% | +39.34% | -10.47% | -6.96% | -37.06% | -32.14% | +112.21% | 12.92B | ||
| -1.37% | +24.04% | +44.13% | +79.86% | +72.78% | +59.27% | +66.51% | -46.61% | - | 12.3B | ||
| +0.31% | +0.15% | +1.64% | +61.81% | +23.10% | +34.71% | -14.64% | -39.35% | +159.81% | 11.25B | ||
| -3.66% | -6.81% | -14.49% | -2.10% | -14.70% | +72.03% | +523.18% | +283.93% | +2,288.37% | 10.6B | ||
| -0.45% | +1.68% | +11.94% | +6.16% | +24.45% | +668.99% | +2,064.07% | +85.96% | - | 10.29B | ||
| +0.07% | -0.22% | +0.44% | +60.35% | +78.26% | +252.96% | +496.67% | - | - | 10.14B | ||
| -4.23% | -0.11% | -11.38% | +14.32% | -11.95% | -27.37% | - | - | - | 9.8B | ||
| +2.43% | +6.33% | +18.15% | +46.94% | +77.58% | +182.05% | +714.17% | +224.14% | +1,248.70% | 9.8B | ||
| +2.60% | +9.18% | +4.74% | +38.92% | +50.87% | +182.53% | +487.24% | +130.63% | - | 9.51B | ||
| +2.45% | +1.20% | +4.21% | -24.37% | -27.65% | +33.58% | +43.53% | +48.17% | +61.47% | 9.28B | ||
| Average | -0.53% | +2.93% | +6.72% | +30.22% | +28.60% | +116.00% | +307.68% | +92.23% | +644.47% | 19.54B | |
| Weighted average by Cap. | -0.84% | +2.82% | +7.44% | +28.17% | +33.36% | +109.22% | +223.25% | +113.90% | +550.17% |
- Stock Market
- Stocks
- CTIC Stock
- Stock
- Sector Cell Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
















